The GLE1 gene helps cells move genetic messages out of the nucleus so the body can make proteins, and if it does not work properly, nerve and muscle development may be affected. This gene plays an important role in early growth and in the health of motor neurons, the nerve cells that control movement. Pathogenic variants can be linked to very low fetal movement, stiff joints at birth, muscle weakness, breathing problems, or a later-onset motor neuron condition.
What is a gene?
Genes are stretches of DNA that provide cells with instructions to make molecules or regulate activities in the body. Some genes hold the code for proteins, the parts of cells that do much of the work. Others mainly direct when certain processes take place, where they occur, and how strongly they happen. As a group, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more in depth explanation, you can read more in the LearnHub.
Overview
GLE1Gene function
What if the gene works
The GLE1 gene helps move messenger RNA, the cell’s working copy of genetic instructions, out of the nucleus so proteins can be made. It also supports normal protein production, especially when cells are under stress.
Risk
What if the gene does not work
More severe variants in the GLE1 gene can cause very low fetal movement, joint contractures, and often death before or shortly after birth. Milder variants may lead to congenital muscle weakness, breathing problems, and delayed motor development.
Treatment
What does that mean for your treatment
No GLE1-specific treatment or drug-selection approach is currently established for pathogenic or loss-of-function variants in the GLE1 gene. Treatment is supportive and based on the person's symptoms and care needs, rather than on a medicine chosen specifically for the GLE1 gene.
Conditions associated with GLE1
Gene function
What if the gene works
Your cells constantly send out RNA messages so proteins can be made at the right time. The GLE1 gene helps those messages leave the nucleus and supports key steps in protein production. Understanding how the GLE1 gene helps cells make proteins gives a clear picture of its day to day role.
The GLE1 gene helps finished messenger RNA, the working copy of genetic instructions, pass from the nucleus into the cell body. It works at nuclear pores, which are tiny gateways, so these messages are released in a usable form.
GLE1 also supports translation, the step where ribosomes read RNA messages to build proteins. This helps protein production start, continue, and finish in a controlled way.
By linking message export with protein making, the GLE1 gene helps your cells turn genetic instructions into action efficiently. This supports steady everyday tasks such as growth, upkeep, and response to normal cellular demands.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help explain normal differences between people, including appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not have any noticeable effect and are part of natural genetic variation. In some situations, though, a variant changes how a gene works more significantly and can contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
When doctors look at how GLE1 gene variants affect cells, many changes appear to alter the protein’s shape, stability, or ability to localize to the nuclear pore, the cell gateway that helps move messenger RNA out of the nucleus. Some variants partly reduce this activity, while more severe variants can leave very little function. This can also disrupt control of protein production inside the cell. In the conditions linked to the GLE1 gene, milder changes are often associated with later onset or less severe features, while more disruptive variants may lead to earlier and broader effects.
How variants are linked to conditions
Pathogenic variants in the GLE1 gene cause a rare group of inherited conditions that affect movement before birth and in early infancy, including lethal congenital contracture syndrome 1 and the related condition lethal arthrogryposis with anterior horn cell disease. These GLE1 gene variants linked to disease usually present with reduced fetal movement, joint contractures, and marked muscle weakness. A smaller number of people have less severe forms and survive beyond infancy.
A variant is not necessarily a diagnosis
Genetic variants are common and are a normal part of human biology. Most do not directly affect health and simply reflect natural human diversity. In many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well understood variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GLE1, risk is mainly related to family inheritance, especially when both parents carry a harmful change in the gene and a child inherits both copies. There is not yet broadly confirmed evidence that lifestyle or environmental factors meaningfully increase or reduce GLE1-related risk.
Inheritance of GLE1 variants
For families asking about the GLE1 inheritance pattern, GLE1-related conditions are inherited in an autosomal recessive way. This means a child usually inherits one altered copy of the GLE1 gene from each parent. Parents who carry one variant are typically called carriers, and with each pregnancy they have a 25% chance of having a child with the condition, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child who inherits neither variant. Sons and daughters are affected at similar rates.
What does my GLE1 result mean for my family?
For families with a disease-causing GLE1 result, the condition is usually passed down in a recessive way. This often means parents are healthy carriers, and brothers, sisters, and future children may also be carriers or, in some families, may be affected. Close relatives may want to learn whether the same family change is present.
Genetic information
Genetic testing
How you find out about variants
Finding out whether you carry a variant in the GLE1 gene usually starts with genetic testing for GLE1 variants using a blood or saliva sample. A lab reads the gene’s DNA sequence and compares it with the usual sequence to identify variants that may help explain a diagnosis or clarify carrier status.
When should I consider getting a genetic test?
Consider genetic testing for the GLE1 gene if your family has a history of a very rare inherited condition linked to reduced fetal movement before birth, stiff joints at birth, or severe early muscle weakness. It may also help explain repeated pregnancies or a baby with these findings.
A genetic result is only one part of your health story
A genetic result can provide helpful insight, but how much it explains depends on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it into tissues, or responds to it at its target. Because of this, the same treatment may work better for one person, seem less effective for another, or cause more side effects in someone who is more sensitive to it. These differences are common and are one reason medication response is not exactly the same from person to person.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences shape the way people respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can help support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the GLE1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or other health concerns are best discussed with your doctor.
History
The GLE1 gene first drew scientific attention through basic cell biology research in the late 1990s, when researchers were identifying genes involved in moving RNA messages inside cells. Building on this early work, scientists uncovered more about the gene when pathogenic variants were linked to a severe inherited condition affecting fetal movement and early survival, first recognized in Finnish families. That discovery helped confirm GLE1 as an important disease gene in human genetics. Later reports showed that some people with variants in GLE1 can have milder childhood presentations, which broadened the medical picture. More recently, research has also linked certain GLE1 variants to some forms of motor neuron disease, adding to the gene’s clinical history.